SG Americas Securities LLC Sells 7,062 Shares of Chemed Co. (NYSE:CHE)

SG Americas Securities LLC decreased its holdings in Chemed Co. (NYSE:CHEFree Report) by 93.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 489 shares of the company’s stock after selling 7,062 shares during the quarter. SG Americas Securities LLC’s holdings in Chemed were worth $294,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in CHE. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Chemed during the 1st quarter worth approximately $1,064,000. ProShare Advisors LLC lifted its position in Chemed by 6,288.9% during the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the period. Sei Investments Co. lifted its position in Chemed by 4.5% during the first quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock worth $26,535,000 after purchasing an additional 1,780 shares during the period. American National Bank & Trust Co. VA acquired a new position in Chemed during the first quarter worth about $3,122,000. Finally, Susquehanna Fundamental Investments LLC acquired a new position in Chemed during the first quarter worth about $4,512,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Chemed news, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares in the company, valued at approximately $3,271,894.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Nicholas Michael Westfall sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total value of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 9,144 shares of company stock valued at $5,264,839 in the last ninety days. 3.32% of the stock is currently owned by insiders.

Chemed Price Performance

Chemed stock opened at $610.18 on Friday. The business has a 50 day moving average of $583.81 and a 200-day moving average of $570.84. Chemed Co. has a 1 year low of $502.64 and a 1 year high of $654.62. The company has a market capitalization of $9.24 billion, a P/E ratio of 32.84, a P/E/G ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. During the same quarter in the previous year, the company posted $4.71 earnings per share. Chemed’s quarterly revenue was up 7.6% on a year-over-year basis. Equities analysts anticipate that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were given a $0.50 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio is presently 10.76%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.